Case reports of suspected adverse drug reactions--systematic literature survey of follow-up

Web references [as supplied by author]

Case reports of suspected adverse reactions

w1. De la Serna Higuera C, Barcena-Marugan R, Aviles J, Nuno J, Cantalapiedra A. Tacrolimus-induced bone marrow suppression. Lancet 1997;350:714-5.

w2. Meeuwisse EJ, Groen FC, Dees A, Smit GH, Ottervanger JP. Lethargy with omeprazole. BMJ 1997;314:481.

w3. Gilroy N, Gottlieb T, Spring P, Peiris O. Trimethoprim-induced aseptic meningitis and uveitis. Lancet 1997;350:112.

w4. Schonhofer PS, Werner B, Troger U. Ocular damage associated with proton pump inhibitors. BMJ 1997;314:1805.

w5. Paar D, Terjung B, Sauerbruch T. Life-threatening interaction between clarithromycin and disopyramide. Lancet 1997;349:326-7.

w6. Brau N, Leaf HL, Wieczorek RL, Margolis DM. Severe hepatitis in three AIDS patients treated with indinavir. Lancet 1997;349:924-5.

w7. Hengel RL, Watts NB, Lennox JL. Benign symmetric lipomatosis associated with protease inhibitors. Lancet 1997;350:1596.

w8. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:180-1.

w9. Carrascosa M, Pascual F, Aresti S. Acarbose-induced acute severe hepatotoxicity. Lancet 1997;349:698-9.

w10. Bagger JP. Adverse event with first-dose perindopril in congestive heart failure. Lancet 1997;349:1671-2.

w11. Johnsson E, Larsson G, Ljunggren M. Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 1997;350:1520.

w12. McBride SR, Lawrence CM, Pape SA, Reid CA. Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis. Lancet 1997;349:101.

w13. Schrijvers D, Slootmaekers V, Dirix L, van-Oosterom A. Neurological disturbances due to filgrastim. Lancet 1997;349:402-3.

w14. Reinhold U, Hartl C, Hering R, Hoeft A, Kreysel HW. Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanoma. Lancet 1997;349:540-1.

w15. Tilelli JA, Heinrichs MM. Adverse reactions to parenteral gold salts. Lancet 1997;349:853.

w16. Larson JT, Skjelbo E, Gram LF. Helicobacter pylori infection (renal toxicity with tetracyclines). Lancet 1997;349:878-9.

w17. Niedermaier G, Briner V. Henoch-Schonlein syndrome induced by carbidopa/levodopa. Lancet 1997;349:1071-2.

w18. Tandan T, Giuffre M, Sheldon R. Exacerbations of neurally mediated syncope associated with sertraline. Lancet 1997;349:1145-6.

w19. Giordano N, Senesi M, Mattii G, Battisti E, Villanova M, Gennari C. Polymyositis associated with simvastatin. Lancet 1997;349:1600-1.

w20. Santonastaso M, Cecchetti E, Pace M, Piccolo D. Yellow palms with disulfiram. Lancet 1997;350:266.

w21. Wiggam MI, Beringer TR. Effect of low-molecular-weight heparin on serum concentrations of potassium. Lancet 1997;350:292-3.

w22. Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet 1997;350:183.

w23. Matsumura T, Maruyama-Tabata H, Kuwahara Y, Sawada T, Ikeda T. Subretinal haemorrhage after granulocyte colony-stimulating factor. Lancet 1997;350:336.

w24. Autret E, Berjot M, Jonville-Bera AP, Aubry MC, Moraine C. Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy. Lancet 1997;350:339.

w25. Schliefer K, Rockstroh JK, Spengler U, Sauerbruch T. Nephrogenic diabetes insipidus in a patient taking cidofovir. Lancet 1997;350:413-4.

w26. Hubner C, Dietz A, Stremmel W, Stiehl A, Andrassy H. Macrolide induced Churg-Strauss syndrome in a patient with atopy. Lancet 1997;350:563.

w27. Bosch X, Bernadich O. Pancreatitis during treatment with amiodarone. Lancet 1997;350:1300.

w28. Viraben R, Lamant L, Brousset P. Losartan-associated atypical cutaneous lymphoid hyperplasia. Lancet 1997;350:1366.

w29. Yeung WL, Ip M, Ng HK, Fok TF. An infant with encephalitis. Lancet 1997;350:1594.

w30. Tamm M, Sieber C, Schnyder F, Haefeli WE. Moxonidine-induced cholestatic hepatitis. Lancet 1997;350:1822.

w31. Shelley WB, Shelley ED. Pseudolymphoma at site of clonidine patch. Lancet 1997;350:1223-4.

w32. Morice AH, Kumwenda J, Qureshi N, Curran A. Mesalazine activation of eosinophil. Lancet 1997;350:1105.

w33. Coutinho AK, de O Santos M, Pinczowski H, Feher O, delGiglio A. Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids. Am J Hematol 1997;54:85-6.

w34. Aul C, Minning H, Sudhoff T, Gattermann N, Heyll A. Recurrent reversible nephrotic syndrome during therapy with recombinant interferon alpha. Am J Hematol 1997;54:91.

w35. Kanjolia A, Valigorsky JM, Joson-Pasion ML. Clozaril-induced lupus anticoagulant. Am J Hematol 1997;54:345-6.

w36. Maurtua M-A, Moscinski L-C, Messina J, Miller L, Ballester OF. Type III hypersensitivity reaction with the use of interferon-alpha. Am J Hematol 1997;55:53-4.

w37. Yokose N, Ogata K, Nakamura K, Kamikubo K, Tamura H, An E, et al. Hypofibrinogenemia induced by prednisolone therapy in a patient with chronic lymphocytic leukemia complicated with autoimmune hemolytic anemia. Am J Hematol 1997;55:166-7.

w38. Shirota T, Yamamoto H, Fujimoto H, Harada Y, Okada K, Uchida H, et al. Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura. Am J Hematol 1997;56:272-6.

w39. Van Gerpen JA. Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS. Neurology 1997;48:537-8.

w40. Gil Nagel A, Gapany S, Blesi K, Villanueva N, Bergen D. Incontinence during treatment with gabapentin. Neurology 1997;48:1467-8.

w41. Esfahani FE, Dasheiff RM. Anemia associated with lamotrigine. Neurology 1997;49:306-7.

w42. Wen PY, Feske SK, Teoh SK, Stieg PE. Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity. Neurology 1997;49:632-3.

w43. Tarsy D. Brachial plexus neuropathy after botulinum toxin injection. Neurology 1997;49:1176-7.

w44. Chattergoon DS, McGuigan MA, Koren G, Hwang P, Ito S. Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid. Neurology 1997;49:1442-4.

w45. Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP. Vigabatrin aggravates absences and absence status. Neurology 1997;49:1467.

w46. Blake G, Murphy S. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment. Neurology 1997;49:1747-8.

w47. Martinez BM, Domingo P. Acute eosinophilic pneumonia associated with tenidap. BMJ 1997;314:349.

w48. Gateley CA, Bundred NJ. Alopecia and breast disease. BMJ 1997;314:481.

w49. Brankin E, Gallagher A, Soukop M. Hypoglycaemia associated with formestane treatment. BMJ 1997;314:869.

w50. Eke T, Bates AK. Acute angle closure glaucoma associated with paroxetine. BMJ 1997;314:1387.

w51. Speight EL, MacSween RM, Stevens A. Persistent itching due to etherified starch plasma expander. BMJ 1997;314:1466-7.

w52. Munera Y, Hugues FC, Le Jeunne C, Pays JF. Interaction of thyroxine sodium with antimalarial drugs. BMJ 1997;314:1593.

w53. Ramachandran S, Giles PD, Hartland A. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment. BMJ 1997;314:1593.

w54. Evans M, Perera PW, Donoghue J. Drug induced psychosis with doxazosin. BMJ 1997;314:1869.

w55. Berent I, Carabeth J, Cordero MM, Cordero R, Sugerman B, Robinson D. Pancreatitis associated with risperidone treatment? Am J Psychiatry 1997;154:130-1.

w56. Warnock JK, Biggs F. Nefazodone-induced hypoglycemia in a diabetic patient with major depression. Am J Psychiatry 1997;154:288-9.

w57. Fogelson DL. Fenfluramine and the cytochrome P450 system. Am J Psychiatry 1997;154:436-7.

w58. Armstrong SC, Schweitzer SM. Delirium associated with paroxetine and benztropine combination. Am J Psychiatry 1997;154:581-2.

w59. Schreiber W, Spernal J. Metronidazole-induced psychotic disorder. Am J Psychiatry 1997;154:1170-1.

w60. Gill DS, Chhetri M, Milne JR. Nephrotic syndrome associated with lithium therapy. Am J Psychiatry 1997;154:1318-9.

w61. Good MI. Lethal interaction of clozapine and buspirone? Am J Psychiatry 1997;154:1472-3.

w62. Ebeling TA, Compton AD, Albright DW. Clozapine-induced stuttering. Am J Psychiatry 1997;154:1473.

w63. Watts BV, Grady TA. Tramadol-induced mania. Am J Psychiatry 1997;154:1624.

Key validation studies

w64. Dobrolet NC, Webber SA, Blatt J, Michaels M, Kiaffas M, Kurland G, et al. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr Transplant 2001;5:125-31.

w65. Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol 2000;50:366-72.

w66. Antonen J, Saha H, Hulkkonen J, Lumio J, Pasternack A, Hurme M. Increased in vitro production of interleukin 6 in response to trimethoprim among persons with trimethoprim induced systemic adverse reactions. J Rheumatol 1999;26:2585-90.

w67. Lutz M, Schwab M, Griese EU, Marx C, Muller-Oerlinghausen B, Schonhofer PS, et al. Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism. Pharmacogenetics 2002;12:73-5.

w68. Echizen H, Tanizaki M, Tatsuno J, Chiba K, Berwick T, Tani M, et al. Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans. Drug Metab Dispos 2000;28:937-44.

W69. Gentile S, Turco S, Guarino G, Sasso FC, Torella R. Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care 1999;22:1217-8.

w70. Gentile S, Turco S, Guarino G, Oliviero B, Annunziata S, Cozzolino D, et al. Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis. Diabetes Obes Metab 2001;3:33-40.

W71. MacFadyen RJ, Lees KR, Reid JL. Differences in first dose response to angiotensin converting enzyme inhibitors in congestive heart failure: a placebo controlled study. Br Heart J 1991;66:206-11.

w72. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, et al. Adverse effects of prenatal methimazole exposure. Teratology 2001;64:262-6.